Renal transplantation: a twenty-five year experience.
Boston has played a significant role in the development of renal transplantation. In Boston was performed the first successful isograft between identical twins (1954) the first successful allograft between fraternal twins (1959) and the first successful allograft from a cadaveric donor (1962). An immunosuppressive drug was also described in Boston by hematologists Schwartz and Dameschek (1959) and modified for renal transplantation in dogs (1961) and used for the first time in a human recipient in March 1962. By 1965 renal transplantation had become a clinical reality. Three hundred and ninety-eight of 589 recipients (68%) since 1950 are still alive, a remarkable figure  considering that it includes all the earliest experimental transplants. One hundred and ninety-five of 295 (68%) with living-related donor transplants still have functioning allografts; 104/265 (39%) with cadaveric donor transplants have functioning grafts currently. Since 1968 transplants from living-related donors have an 80% one year survival whereas cadaveric donor transplants have approximately a 50% one year survival. Seventy-nine per cent of all one year survivors have had excellent psycho-social rehabilitation.
D000818:Animals; D001900:Boston; D002102:Cadaver; D004285:Dogs; D005260:Female; D005500:Follow-Up Studies; D006666:History of Medicine; D006801:Humans; D007165:Immunosuppression Therapy / Q000266:history; D016030:Kidney Transplantation; D011247:Pregnancy; D014180:Transplantation / Q000266:history*; D014184:Transplantation, Homologous / Q000266:history / Q000401:mortality; D014430:Twins, Monozygotic